Companies /Healthcare

High Tide Inc

NASDAQ: HITI Pharmaceutical Retailers
$2.58
▲ $0.00 (+0.00%) today
Markets closed · 12:50am ET

24/7 Wall St. View

HITI at a Glance

Valuation
Market cap
$230.0M
Profitability
Revenue (TTM)
$720.5M
Profit margin
-4.6%
EPS (TTM)
$-0.31
Price
52-week range
$2 – $4
Street target
$4.67
Earnings
Q3 2026 EPS
$0.09
vs. $0.02 est.
+311.4%

Headquartered in Calgary, AB Fiscal year ends October NASDAQ: HITI hightideinc.com

About High Tide

High Tide Inc. is a vertically integrated cannabis enterprise operating across retail, medical cannabis distribution, e-commerce, and white label products. Its wholly owned subsidiary Canna Cabana is the largest cannabis retail chain in Canada with 232 domestic locations and one international location in Berlin, Germany, spanning British Columbia, Alberta, Saskatchewan, Manitoba, and Ontario. Canna Cabana pioneered the cannabis discount club retail model and operates the world's largest cannabis loyalty program, Cabana Club, with over 2.73 million members, including a paid ELITE tier exceeding 186,000 members. In medical cannabis distribution, the company's majority-owned subsidiary Remexian Pharma GmbH is a German pharmaceutical company holding approximately 10.5% of the German medical cannabis market, licensed to import from 19 countries. High Tide also operates multiple global e-commerce platforms for accessories and hemp-derived products, including U.S.-based NuLeaf Naturals focused on hemp-derived CBD. The company develops white label cannabis products under its Queen of Bud and Cabana Cannabis Co. brands. High Tide trades on Nasdaq and the TSX Venture Exchange under the ticker HITI. Updated

HITI Coverage

Frequently Asked Questions

What does High Tide do?

High Tide Inc. is a vertically integrated cannabis enterprise operating across retail, medical cannabis distribution, e-commerce, and white label products.

What is the HITI stock price target?

The Wall Street consensus 12-month price target for HITI is $4.67.